Base Editing Rewrites Embryo Genomes Precisely

In a preprint, Dieter Egli at Columbia University and colleagues tested adenine base editors (ABEs), which convert individual DNA letters without creating the double-strand breaks that are characteristic of standard CRISPR-Cas9. The team introduced A→G edits into the PCSK9 gene, which is linked to cholesterol regulation, and into the fetal haemoglobin genes HBG1/2, which are relevant to sickle cell disease and β-thalassaemia. Base editing was efficient in human embryos and, unlike Cas9-mediated editing, did not produce detectable large deletions or chromosomal abnormalities at the target sites.

Embryos edited with ABE delivered as ribonucleoprotein complexes developed to the blastocyst stage and yielded embryonic stem-cell lines carrying the intended edits. However, mosaicism remained common, meaning not all cells within an embryo carried the same edit, and off-target editing varied substantially depending on the guide RNA used. The authors conclude that base editing appears substantially less genotoxic than CRISPR-Cas9 in human embryos, but is not ready for clinical application due to unresolved issues including mosaicism, off-target activity and the need for further safety studies.

A Nature News commentary places the findings in the context of the field's ongoing efforts to overcome the chromosome loss and genome instability previously observed after CRISPR-Cas9 editing in embryos. Experts quoted in the commentary described the work as a significant technical advance, while others warned that the demonstration of precise embryo editing could accelerate commercial interest in germline genome modification before the technology is sufficiently understood. It also notes the lingering impact of the 2018 He Jiankui scandal and emphasises that the current work remains a laboratory study rather than a step towards clinical embryo editing.

The study was led by Stepan Jerabek and Dieter Egli at Columbia University, and it was posted as a bioRxiv preprint on 1 June 2026. This article also draws on a Nature News from 5 June 2026.